Works matching IS 09066705 AND DT 2024 AND VI 33 AND IP 9
Results: 15
IL23R mutations associated with decreased risk of psoriasis lead to the differential expression of genes implicated in the disease.
- Published in:
- Experimental Dermatology, 2024, v. 33, n. 9, p. 1, doi. 10.1111/exd.15180
- By:
- Publication type:
- Article
Interleukin‐1 family cytokines and soluble receptors in hidradenitis suppurativa.
- Published in:
- Experimental Dermatology, 2024, v. 33, n. 9, p. 1, doi. 10.1111/exd.15179
- By:
- Publication type:
- Article
Efficacy and safety of ritlecitinib in vitiligo patients across Fitzpatrick skin types with biomarker analyses.
- Published in:
- Experimental Dermatology, 2024, v. 33, n. 9, p. 1, doi. 10.1111/exd.15177
- By:
- Publication type:
- Article
Biodistribution of iron oxide tattoo pigment: An experimental murine study.
- Published in:
- Experimental Dermatology, 2024, v. 33, n. 9, p. 1, doi. 10.1111/exd.15183
- By:
- Publication type:
- Article
Identification of dietary factors that impact the gut microbiota associated with vitiligo: A Mendelian randomization study and meta‐analysis.
- Published in:
- Experimental Dermatology, 2024, v. 33, n. 9, p. 1, doi. 10.1111/exd.15176
- By:
- Publication type:
- Article
Possibility of maintaining remission with topical therapy alone after withdrawal of dupilumab in Japanese patients with atopic dermatitis and their characteristics in the real world.
- Published in:
- Experimental Dermatology, 2024, v. 33, n. 9, p. 1, doi. 10.1111/exd.15175
- By:
- Publication type:
- Article
Psoriasiform drug eruption: A case series with a review of the literature.
- Published in:
- Experimental Dermatology, 2024, v. 33, n. 9, p. 1, doi. 10.1111/exd.15174
- By:
- Publication type:
- Article
Comparison of serum cytokines and chemokines levels and clinical significance in patients with pemphigus vulgaris—A retrospective study.
- Published in:
- Experimental Dermatology, 2024, v. 33, n. 9, p. 1, doi. 10.1111/exd.15173
- By:
- Publication type:
- Article
Causal effects of lipid‐lowering drugs on inflammatory skin diseases: Evidence from drug target Mendelian randomisation.
- Published in:
- Experimental Dermatology, 2024, v. 33, n. 9, p. 1, doi. 10.1111/exd.15157
- By:
- Publication type:
- Article
Granzyme B inhibition reduces autoantibody‐induced dermal–epidermal separation in an ex vivo model of epidermolysis bullosa acquisita.
- Published in:
- Experimental Dermatology, 2024, v. 33, n. 9, p. 1, doi. 10.1111/exd.15172
- By:
- Publication type:
- Article
Exploration of potential biomarkers for prurigo nodularis based on plasma‐metabolome analysis.
- Published in:
- Experimental Dermatology, 2024, v. 33, n. 9, p. 1, doi. 10.1111/exd.15170
- By:
- Publication type:
- Article
Treatment of malignant melanoma with coxsackievirus A21 (V937): An emerging oncolytic virotherapy.
- Published in:
- Experimental Dermatology, 2024, v. 33, n. 9, p. 1, doi. 10.1111/exd.15169
- By:
- Publication type:
- Article
Predictive value of disease activity signs in vitiligo: An observational study.
- Published in:
- Experimental Dermatology, 2024, v. 33, n. 9, p. 1, doi. 10.1111/exd.15167
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Experimental Dermatology, 2024, v. 33, n. 9, p. 1, doi. 10.1111/exd.15161
- Publication type:
- Article
Evaluation of Sézary cell marker expression and cell death behaviour upon in vitro treatment by flow cytometry in Sézary syndrome patients.
- Published in:
- Experimental Dermatology, 2024, v. 33, n. 9, p. 1, doi. 10.1111/exd.15171
- By:
- Publication type:
- Article